SCHEMBL18358908

SCHEMBL18358908

CC1(S)CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18358922 0.77
SCHEMBL18358896 0.77
SCHEMBL18358897 0.77
SCHEMBL27993609 0.75
SCHEMBL2010663 0.73
SCHEMBL29414201 0.73
SCHEMBL13326775 0.73
SCHEMBL18358866 0.73
SCHEMBL18358837 0.73
SCHEMBL1645033 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125737-A1 HETEROCYCLIC COMPOUNDS AND USE THEREOF SILEXON AI TECHNOLOGY CO., LTD. (CN) 2023-07-06 WO disclosed
US-20230115413-A1 Use of Thiol Compounds to Treat Neurological Disease ZANKEL, TODD C, MR 2023-04-13 US disclosed
US-20220024920-A1 ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF HORIZON ORPHAN LLC (US) 2022-01-27 US disclosed
US-20210069129-A1 Use of Thiol Compounds to Treat Neurological Disease ZANKEL, TODD C, MR 2021-03-11 US disclosed
US-10906904-B2 ADO-resistant cysteamine analogs and uses thereof HORIZON ORPHAN LLC (US) 2021-02-02 US disclosed
EP-3316877-B1 ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF HORIZON ORPHAN LLC (US) 2019-10-30 EP disclosed
EP-3159341-B1 PYRIDINO[1,2-A]PYRIMIDONE ANALOGUE USED AS PI3K INHIBITOR CHAI TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2019-08-21 EP disclosed
US-20190029977-A1 Use of Thiol Compounds to Treat Neurological Disease ZANKEL, TODD C, MR 2019-01-31 US disclosed
WO-2017004485-A1 ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF RAPTOR PHARMACEUTICALS INC. (US) 2017-01-05 WO disclosed